Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 36, 2004 - Issue 6-7
Submit an article Journal homepage
14
Views
6
CrossRef citations to date
0
Altmetric
Original Paper

Evaluation of Restriction Endonuclease Analysis of BRO Beta-lactamases in Clinical and Carrier Isolates of Moraxella catarrhalis

Özgen Köseoglu Department of Microbiology and Clinical Microbiology, Faculty of Medicine, AnkaraCorrespondence[email protected])
,
Alper Ergin School of Health Services, Hacettepe University, Ankara
&
Gülsen Hascelik Department of Microbiology and Clinical Microbiology, Faculty of Medicine, Ankara
Pages 431-434 | Received 10 Feb 2004, Published online: 08 Jul 2009

References

  • Murphy T. Moraxella (Branhamella) catarrhalis and other Gram-negative cocci. In: Mandell, Bennett, Dolin, eds. Principles and Practice of Infectious Disease, 5th edn. Edinburgh: Churchill Livingstone; 2000. p. 2259–65.
  • Carr B, Walsh JB, Coakley D, Mulvihill E, Keane C. Prospective hospital study of community acquired lower respiratory tract infection in the elderly. Respiratory Medicine 1991; 85: 18–7.
  • Verduin CM, Hol C, Fleer A, Dijk H, Belkum A. Moraxella catarrhalis: from emerging to established pathogen. Clin Microbiol Rev 2002; 15: 125–44.
  • Wallace RJ Jr, Nash DR, Steingrube VA. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Am J Med 1990; 88: S46–50.
  • Bootsma HJ, Dijk HV, Verhoef J, Fleer A, Mooi FT. Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis. Antimicrob Agents Chemother 1996; 40: 966–72.
  • Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557–84.
  • Richter SS, Winokur PL, Brueggemann AB, Huynh HK, Rhonmberg PR, Wingert EM, Doern GV. Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 US medical centres during 1994–1995 and 1997–1998. Antimicrob Agents Chemother 2000; 44: 444–6.
  • Boostma HJ, Dijk H, Vauterin P, Verhoef J, Mooi FR. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer. Mol Microbiol 2000; 36: 93–104.
  • Plessis M. Rapid discrimination between BRO beta-lactamases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis. Diagn Microbiol Infect Dis 2001; 39: 65–77.
  • National Committee for Clinical Laboratory Standards 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5, 5th edn. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • National Committee for Clinical Laboratory Standards 2002. Performance standards for antimicrobial susceptibility testing: supplemental tables. M100–S12. National Committee for Clinical Laboratory Standards, Wayne, Pa.
  • McGregor K, Chang BJ, Mee BJ, Riley TV. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases. Eur J Clin Microbiol Infect Dis 1998; 17: 219–34.
  • Schmitz FJ, Beeck A, Perdikouli M, Boos M, Mayer S, Scheuring S, et al. Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates. J Clin Microbiol 2002; 40: 1546–8.
  • Sweeney KG, Berghese A, Needham CA. In vitro susceptibilities of isolates from patients with Branhamella catarrhalis pneumonia compared with those of colonizing strains. Antimicrob Agents Chemother 1985; 27: 499–502.
  • Bootsma HJ, Aerts PC, Posthuma G, Harmsen T, Verhoef J, Disk H, Mooi FR. Moraxella (Branhamella) catarrhalis BRO beta-lactamase: a lipoprotein of Gram-positive origin? J Bacteriol 1999; 181: 5090–3.
  • Fung C, Yeo S, Livermore DM. Susceptibility of Moraxella catarrhalis isolates to beta-lactam antibiotics in relation to beta-lactamase pattern. J Antimicrob Chemother 1994; 33: 215–22.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.